Your prediction
Atea ASA Stock
Atea ASA shows a slight decrease today, losing -€0.040 (-0.250%) compared to yesterday.
Pros and Cons of Atea ASA in the next few years
Pros
?
B****
?
S********** s********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Atea ASA vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Atea ASA | -0.250% | 5.914% | 3.277% | 30.033% | 19.394% | 30.680% | -1.129% |
| ELF Beauty Inc | 0.030% | 5.671% | 11.091% | -32.311% | 5.827% | -32.785% | - |
| Natural Grocers By Vit. Cot. | -2.110% | 8.594% | 2.963% | -15.244% | 29.907% | 150.450% | 194.180% |
| Designer Brands Inc. | -0.930% | 13.347% | 5.941% | 115.726% | -18.321% | -41.209% | -54.661% |
News
Atea Pharmaceuticals Q1 Earnings Call Highlights
Atea Pharmaceuticals (NASDAQ:AVIR) said it remains on track for two key Phase 3 hepatitis C readouts in 2026 while advancing a newer hepatitis E program aimed at immunocompromised patients with no
